Great News
Recently, the Beijing Municipal Bureau of Economy and Information Technology (BMEIT) officially announced the proposed recognition list for the first batch of "2025 Beijing Advanced-Level Smart Factories". Among them, Beijing Chunlizhengda Medical Instruments Co., Ltd. (hereinafter referred to as "Chunli Medical") was successfully selected. This selection was conducted in accordance with the requirements of the Implementation Plan for the Gradient Cultivation of Smart Factories jointly issued by the Ministry of Industry and Information Technology (MIIT) and five other national authorities. After going through various stages including enterprise application, district-level recommendation, and expert review, the proposed recognition list was finally determined.
Selection Background
To accelerate the development of intelligent manufacturing, the Beijing Municipal Bureau of Economy and Information Technology has incorporated enterprises with completed smart factories and digital workshops into the gradient cultivation system for smart factories. This selection initiative aims to drive the intelligent and digital transformation of Beijing's manufacturing sector and enhance industrial competitiveness by leveraging the exemplary and leading role of benchmark enterprises. Enterprises on the list will be entitled to policy support to further advance their intelligent upgrading, thus contributing to the high-quality development of Beijing's manufacturing industry.
Continuous innovation, leading the trend
As a representative enterprise in the biopharmaceutical sector of Tongzhou District, Chunli Medical has delivered an outstanding performance in the construction of its smart factory. By applying intelligent production equipment and a digital management system, the company has greatly improved production efficiency and product quality, setting a benchmark for the intelligent transformation of the biopharmaceutical industry.
Innovation has always been a top priority for Chunli Medical, which continuously explores and experiments with new technologies. In the process of building its smart factory, the company has actively adopted the concept of Industry 4.0. Through sustained technological innovation, it has ensured the advancedness and foresight of the project.
Talent development, creating core competitiveness
The efficient operation of a smart factory is inseparable from a high-caliber talent team. Chunli Medical attaches great importance to talent cultivation and recruitment, and has supplied a large number of technical and managerial professionals to its smart factory through university collaborations and internal training programs.
Lean management, improving efficiency
In the management of its smart factory, Chunli Medical has adopted the lean production methodology. By continuously optimizing processes and reducing waste, the company has achieved a substantial improvement in production efficiency.
Green and environmentally friendly, fulfilling social responsibility
The construction of its smart factory also reflects Chunli Medical's commitment to environmental protection. By adopting energy-saving technologies and recycling resources, Chunli Medical has not only reduced production costs, but also actively fulfilled its corporate social responsibilities.
Forge ahead with determination
Taking this as an opportunity, Chunli Medical will continue to deepen its commitment to technological innovation and actively expand both domestic and international markets to further enhance its core competitiveness. Striving forward steadily on the path of driving industrial development and fulfilling corporate social responsibilities, the company will forge ahead toward higher goals, create greater achievements, make a more outstanding contribution to the development of the medical industry in Beijing and even across the whole nation, and open a brand-new chapter for itself.
Company Profile
Beijing Chunli Zhengda Medical Instruments Co., Ltd. (abbreviated as "Chunli Medical") was founded in 1998. It is mainly engaged in the R&D, production and sales of medical devices such as orthopedic, dental, biomedical materials and surgical robots. After nearly three decades of development, Chunli Medical has become the only A+H - listed enterprise in the orthopedic and dental sectors. It boasts national - level R&D platforms including a National Enterprise Technology Center and a National Postdoctoral Research Station. It also holds the titles of National Manufacturing Single Champion Enterprise, National High - and New - Tech Enterprise, National Specialized, Sophisticated, Unique and New "Little Giant" Enterprise, National Intellectual Property Advantage Enterprise, and Zhongguancun High - and New - Tech Enterprise. The company has taken the lead in two national key R&D programs and is the only domestic enterprise that has widely applied tantalum in joint, dental, spinal and sports medicine products. It has also led four "Challenging the List and Taking Command" projects initiated by the Ministry of Industry and Information Technology, which has promoted the industrialization of magnesium alloy, hydroxyapatite and tantalum, as well as their clinical application in the domestic dental field. Additionally, the surgical robot project it led under the "Challenging the List and Taking Command" initiative has been awarded the title of "Outstanding Unit", accelerating the R&D and clinical promotion of domestic surgical robots.
